# Chin Instrument

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chin-instrument

- Industry: Industrial Machinery
- Headquarters: Hefei, China
- Latest round: Series A (Apr 15, 2024)
- Investors on record: 8

## About

Based in Shenzhen, China, and established in 2018, Chin Instrument is an instrument company that focuses on the fields of mass spectrometers for detection. The company's team is from Tsinghua University Instrument Science and Technology Research Team, and its team members have 9 doctors. The company has applied for more than 50 items of invention patents about mass spectrometers, including 34 items of mandate patents. It has cooperated with the China Academy of Food and Drug Testing and Certification, China Academy of Inspection and Quarantine Sciences, China Agricultural University, etc. In 2018, it launched the first generation product, Kyrin-2. In April 2024, Chin Instrument raised series A+ funding.

Chin Instrument develops mass spectrometer products with injection systems, ion sources, mass analyzers, detectors and data systems as the core. Its products include Kyrin series small mass spectrometers, phoenix series small mass spectrometers, and mass spectrometer peripherals products and related components. The company also provides users with services such as sample pre-treatment, ionization, injection interface, analytical methods, etc. Mass spectrometers can be used in the fields of food safety, healthcare, education and research, public safety, environmental monitoring, and marine energy.

Chin Instrument generates revenue by providing the mass spectrometers for detection and services.

The company will focuses on the construction and investment of headquarters, R&D center, manufacturing base.

## Funding rounds

- Series A, Apr 15, 2024 — Junsan Capital, Anhui Guoyao Venture Capital Management, Feixi Urban and Rural Construction Investment
- Series A, Apr 25, 2023 — Leaguer Group, Shenzhen HTI, Sage Ventures, Shenzhen Bioeasy Biotechnology Co., Ltd
- Angel, Apr 1, 2019 — Leaguer Group, TusStar

## Investors

- Leaguer Group (https://capitalatlas.ai/funds/leaguer-group) — Angel, Series A
- TusStar (https://capitalatlas.ai/funds/tusstar) — Angel
- Shenzhen HTI (https://capitalatlas.ai/funds/shenzhen-hti) — Series A
- Sage Ventures (https://capitalatlas.ai/funds/sage-ventures) — Series A
- Shenzhen Bioeasy Biotechnology Co., Ltd — Series A
- Junsan Capital (https://capitalatlas.ai/funds/junsan-capital) — Series A
- Anhui Guoyao Venture Capital Management (https://capitalatlas.ai/funds/anhui-guoyao-venture-capital-management) — Series A
- Feixi Urban and Rural Construction Investment — Series A